Your browser doesn't support javascript.
loading
DDInter: an online drug-drug interaction database towards improving clinical decision-making and patient safety.
Xiong, Guoli; Yang, Zhijiang; Yi, Jiacai; Wang, Ningning; Wang, Lei; Zhu, Huimin; Wu, Chengkun; Lu, Aiping; Chen, Xiang; Liu, Shao; Hou, Tingjun; Cao, Dongsheng.
Afiliação
  • Xiong G; Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
  • Yang Z; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China.
  • Yi J; Hunan Key laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha 410013, Hunan, China.
  • Wang N; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China.
  • Wang L; Hunan Key laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha 410013, Hunan, China.
  • Zhu H; College of Computer, National University of Defense Technology, Changsha 410073, Hunan, China.
  • Wu C; Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
  • Lu A; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China.
  • Chen X; Hunan Key laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha 410013, Hunan, China.
  • Liu S; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China.
  • Hou T; Hunan Key laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha 410013, Hunan, China.
  • Cao D; College of Computer, National University of Defense Technology, Changsha 410073, Hunan, China.
Nucleic Acids Res ; 50(D1): D1200-D1207, 2022 01 07.
Article em En | MEDLINE | ID: mdl-34634800
ABSTRACT
Drug-drug interaction (DDI) can trigger many adverse effects in patients and has emerged as a threat to medicine and public health. Despite the continuous information accumulation of clinically significant DDIs, there are few open-access knowledge systems dedicated to the curation of DDI associations. To facilitate the clinicians to screen for dangerous drug combinations and improve health systems, we present DDInter, a curated DDI database with comprehensive data, practical medication guidance, intuitive function interface, and powerful visualization to the scientific community. Currently, DDInter contains about 0.24M DDI associations connecting 1833 approved drugs (1972 entities). Each drug is annotated with basic chemical and pharmacological information and its interaction network. For DDI associations, abundant and professional annotations are provided, including severity, mechanism description, strategies for managing potential side effects, alternative medications, etc. The drug entities and interaction entities are efficiently cross-linked. In addition to basic query and browsing, the prescription checking function is developed to facilitate clinicians to decide whether drugs combinations can be used safely. It can also be used for informatics-based DDI investigation and evaluation of other prediction frameworks. We hope that DDInter will prove useful in improving clinical decision-making and patient safety. DDInter is freely available, without registration, at http//ddinter.scbdd.com/.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Software / Bases de Dados Factuais / Interações Medicamentosas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Software / Bases de Dados Factuais / Interações Medicamentosas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Idioma: En Ano de publicação: 2022 Tipo de documento: Article